These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention. De Lorenzo F; Saba N; Kakkar VV Drugs; 2003; 63(6):565-76. PubMed ID: 12656654 [TBL] [Abstract][Full Text] [Related]
5. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism]. Prati PL; Piazza V Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604 [TBL] [Abstract][Full Text] [Related]
7. What is the appropriate approach to prevention of thromboembolism in heart failure? Freudenberger RS; Schumaecker MM; Homma S Thromb Haemost; 2010 Mar; 103(3):489-95. PubMed ID: 20024492 [TBL] [Abstract][Full Text] [Related]
8. [Deep vein thrombosis and thromboembolism in arthroscopic surgery]. Mann G; Hetsroni I; Mei-Dan O; Shabat S; Barchilon V; Mann A; Nyska M Harefuah; 2008 Oct; 147(10):797-800, 837. PubMed ID: 19039910 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm. Lip GY; Gibbs CR Cochrane Database Syst Rev; 2001; (4):CD003333. PubMed ID: 11687189 [TBL] [Abstract][Full Text] [Related]
10. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH; Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. Lip GY; Gibbs CR QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151 [TBL] [Abstract][Full Text] [Related]
12. What do we know about anticoagulation in patients with heart failure? Ahnert AM; Freudenberger RS Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211 [TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy for heart failure in sinus rhythm. Subramaniam V; Davis RC; Shantsila E; Lip GY Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305 [TBL] [Abstract][Full Text] [Related]
14. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm? ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508 [TBL] [Abstract][Full Text] [Related]
15. Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: a nationwide cohort study. Wolsk E; Lamberts M; Hansen ML; Blanche P; Køber L; Torp-Pedersen C; Lip GY; Gislason G Eur J Heart Fail; 2015 Aug; 17(8):828-36. PubMed ID: 26136386 [TBL] [Abstract][Full Text] [Related]
16. Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients. Cioffi G; Pozzoli M; Forni G; Franchini M; Opasich C; Cobelli F; Tavazzi L Eur Heart J; 1996 Sep; 17(9):1381-9. PubMed ID: 8880024 [TBL] [Abstract][Full Text] [Related]